<Record>
<Term>K-RAS VAL-12 Mutant Protein</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<SemanticType>Amino Acid, Peptide, or Protein</SemanticType>
<ParentTerm>Mutated Ras Peptide</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Biological Agent/Antigen/Vaccine Antigen/Mutated Ras Peptide/K-RAS VAL-12 Mutant Protein</ClassificationPath>
<BroaderTerm>Mutated Ras Peptide</BroaderTerm>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Biological Agent</BroaderTerm>
<BroaderTerm>Antigen</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>K-RAS VAL-12 Mutant Protein</BroaderTerm>
<BroaderTerm>Vaccine Antigen</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<Synonym>K-RAS VAL-12 Mutant Protein</Synonym>
<Description>A synthetic form of the K-ras protein containing a point mutation at position 12 (glycine to valine). Vaccines using mutant K-ras proteins may be used in the immunotherapy of various cancers that express mutated K-ras proteins. (NCI04)</Description>
<Source>NCI Thesaurus</Source>
</Record>
